Related Experiment Video
Updated: Jan 17, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
Quantitative C-reactive protein for differentiating tuberculous and malignant pleural effusion: A cross-sectional
Narayan Prakash Sharma1, Ranjan Sapkota2, Prajjwol Luitel3
1Department of General Surgery, Maharajgunj Medical Campus, Tribhuvan University, Teaching Hospital, Maharajgunj, Kathmandu, Nepal.
Indian Journal of Thoracic and Cardiovascular Surgery
|September 23, 2025
Summary
Quantitative C-reactive protein (qCRP) in pleural fluid can help distinguish tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE). This simple test offers a cost-effective diagnostic tool for resource-limited settings.
Area of Science:
- Pulmonology
- Oncology
- Infectious Diseases
Background:
- Lymphocyte-rich pleural effusion is commonly caused by tuberculosis and malignancy.
- Diagnosing pleural effusion in resource-limited settings presents challenges.
- A simple diagnostic test is needed to differentiate causes of pleural effusion.
Purpose of the Study:
- To evaluate the diagnostic utility of quantitative C-reactive protein (qCRP) for differentiating tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE).
Main Methods:
- A cross-sectional study involving 81 patients with lymphocyte-rich exudative pleural effusion.
- Biochemical analyses of pleural fluid qCRP levels and pathological examinations.
- Statistical analysis including t-test, chi-square test, multivariate logistic regression, and ROC curve analysis.
Main Results:
- Tuberculous pleural effusion (TPE) showed significantly higher pleural fluid qCRP levels (55.5 mg/L) compared to malignant pleural effusion (MPE) (18.6 mg/L).
- A pleural fluid CRP cutoff of ≥24.1 mg/L demonstrated 65.9% sensitivity and 73.5% specificity for predicting TPE.
Conclusions:
- Pleural fluid qCRP is a valuable tool for differentiating TPE from MPE.
- The test is simple, rapid, and cost-effective.
- qCRP aids in diagnosing lymphocyte-rich exudative pleural effusion in challenging environments.
Related Concept Videos
Pulmonary Tuberculosis IV
479
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
479
Pneumonia III: Complications and Assessment
788
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
788
Pulmonary Tuberculosis III
941
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
941

